Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors

Summary

Decoy Therapeutics nominates Patricia Gauthier, a global biopharma executive, for election to the company's Board of Directors. The company is a biotechnology firm focused on developing Designable Multi-Antivirals (D-MAVs) to target shared viral mechanisms.